Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of dexmedetomidine dose for conscious sedation in dental and minor maxillofacial surgery
2014-002243-17Phase 4Terminated
- Sponsor
- Clínica Universidad de Navarra
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in None (3 arms), sponsored by Clínica Universidad de Navarra. Primary endpoints: Need for dexmedetomidine loading dose to achieve target BIS sedation levels and Optimal maintenance dose of dexmedetomidine for satisfactory sedation. Started Jun 2014; status: terminated.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on 2014-002243-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002243-17.